Does UPADACITINIB Cause Arterial thrombosis? 6 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Arterial thrombosis have been filed in association with UPADACITINIB (Rinvoq). This represents 0.0% of all adverse event reports for UPADACITINIB.
6
Reports of Arterial thrombosis with UPADACITINIB
0.0%
of all UPADACITINIB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Arterial thrombosis From UPADACITINIB?
Of the 6 reports, 1 (16.7%) required hospitalization.
Is Arterial thrombosis Listed in the Official Label?
Yes, Arterial thrombosis is listed as a known adverse reaction in the official FDA drug label for UPADACITINIB.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Arterial thrombosis?
RIVAROXABAN (60)
HEPARIN (55)
APIXABAN (51)
BEVACIZUMAB (47)
CISPLATIN (47)
PREDNISOLONE (45)
CAPECITABINE (36)
LENALIDOMIDE (34)
CARBOPLATIN (32)
OXALIPLATIN (32)
Which UPADACITINIB Alternatives Have Lower Arterial thrombosis Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL